Physician profile
Lara Kozin
NPI 1235584616
$5,367.45
in general payments reported to CMS, 2019-2025
23 companies · $684 in 2025
The $684 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.06 · 2021: $21.88 · 2022: $3,343 · 2023: $237 · 2024: $1,068 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,687 · Travel and Lodging: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,686.51 |
| Travel and Lodging | $302.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $2,509.02 | 2022-2023 | |
| Stryker Corporation | $1,722.95 | 2022-2025 | Infinity, Prostep, Citrefix |
| Musculoskeletal Transplant Foundation INC. | $285.33 | 2022-2025 | |
| Smith+Nephew, INC. | $144.18 | 2021-2025 | Collagenase Santyl, Grafix Pl, Stravix Pl |
| Ossio INC | $132.01 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $114.86 | 2022-2023 | Seglentis |
| Treace Medical Concepts, INC. | $46.85 | 2022-2025 | |
| Integra Lifesciences Corporation | $46.26 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Reapplix INC. | $44.35 | 2023 | 3c Patch Kit - Box |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $43.87 | 2022-2024 | Jublia |
| Convatec INC. | $43.05 | 2023 | |
| Paratek Pharmaceuticals, INC. | $32.37 | 2025 | Nuzyra |
| Medshape, INC. | $26.57 | 2023 | Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm, Dynanail |
| Molnlycke Health Care US, LLC | $21.92 | 2023 | Setopress |
| Hydrofera LLC | $20.23 | 2024 | Hydrofera Blue |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $19.30 | 2022 | |
| Tactile Systems Technology INC | $18.62 | 2025 | Flexitouch Plus, Nimbl |
| Grt US Holding, INC. | $18.46 | 2022 | |
| Solventum Corporation | $16.91 | 2025 | V.A.C.Ulta |
| Abbott Laboratories | $16.43 | 2024 | Proclaim |
| Kerecis Limited | $16.31 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Sebela Pharmaceuticals INC. | $14.06 | 2019 | |
| Zimmer Biomet Holdings, INC. | $13.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lara Kozin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.